Odacite Flex Perfecting
- Manufacturer
- Odacite Beauty | Nanophase Technologies Corporation
- Effective date
- 2024-10-25
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 20:51:14
Label at a glance#
ProductOdacite Flex Perfecting
Active ingredientZINC OXIDE
Label structure8 sections
Label contents#
Full prescribing information#
Odacite Flex Perfecting
Odacite Flex Perfecting
Odacite Flex Perfecting
Odacite Flex Perfecting
Odacite Flex Perfecting
Odacite Flex Perfecting
Odacite Flex Perfecting
Products#
Every source-derived product name is available through these pages.
- Odacite Flex Perfecting
- Zinc Oxide
- GLYCERIN
- JOJOBA OIL
- ORYZA SATIVA WHOLE
- TRIDECYL SALICYLATE
- SILICON DIOXIDE
- TOCOPHEROL
- CAPRYLYL GLYCOL
- COCO-CAPRYLATE
- NYLON-12
- PHENYLPROPANOL
- HELIANTHUS ANNUUS FLOWERING TOP
- LECITHIN, SOYBEAN
- METHYLHEPTYL ISOSTEARATE
- METHYLPROPANEDIOL
- ALLANTOIN
- ALKYL (C12-15) BENZOATE
- ROSMARINUS OFFICINALIS FLOWER
- .ALPHA.-BISABOLOL, (+)-
- SODIUM HYDROXIDE
- WATER
- NIACINAMIDE
- PROPANEDIOL
- TETRASODIUM GLUTAMATE DIACETATE
- SODIUM CHLORIDE
- POLYGLYCERYL-4 DIISOSTEARATE/POLYHYDROXYSTEARATE/SEBACATE
- CHAMOMILE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 82088-167 | 82088-167-01, 82088-167-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 254c9178-e695-8324-e063-6294a90aa167 | fa3e58ed-b41f-642b-e053-6294a90aa0ea | 2024-10-25 | Warnings | 254c9178-e695-8324-e063-6294a90aa167 fa3e58ed-b41f-642b-e053-6294a90aa0ea |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
